CHF6.18
4.22% yesterday
SIX Swiss Exchange, Oct 03, 05:30 pm CET
ISIN
CH0042615283
Symbol
DOCM

DocMorris Target price 2025 - Analyst rating & recommendation

DocMorris Classifications & Recommendation:

Buy
57%
Hold
36%
Sell
7%

DocMorris Price Target

Target Price CHF10.20
Price CHF6.18
Potential
Number of Estimates 9
9 Analysts have issued a price target DocMorris 2026 . The average DocMorris target price is CHF10.20. This is higher than the current stock price. The highest price target is
CHF18.10 192.82%
register free of charge
, the lowest is .
A rating was issued by 14 analysts: 8 Analysts recommend DocMorris to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DocMorris stock has an average upside potential 2026 of . Most analysts recommend the DocMorris stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion CHF 1.02 1.16
4.91% 14.15%
EBITDA Margin -5.65% -4.00%
42.87% 29.26%
Net Margin -9.56% -9.51%
212.66% 0.54%

10 Analysts have issued a sales forecast DocMorris 2025 . The average DocMorris sales estimate is

CHF1.2b
Unlock
. This is
13.54% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF1.3b 3.49%
Unlock
, the lowest is
CHF1.1b 20.77%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF1.0b 4.91%
2025
CHF1.2b 14.15%
Unlock
2026
CHF1.4b 18.17%
Unlock
2027
CHF1.6b 15.89%
Unlock
2028
CHF1.9b 22.33%
Unlock
2029
CHF2.2b 14.70%
Unlock
2030
CHF2.5b 12.15%
Unlock
2031
CHF2.7b 6.12%
Unlock
2032
CHF2.8b 6.14%
Unlock

10 Analysts have issued an DocMorris EBITDA forecast 2025. The average DocMorris EBITDA estimate is

CHF-46.5m
Unlock
. This is
28.99% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF-41.5m 36.66%
Unlock
, the lowest is
CHF-50.0m 23.67%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CHF-57.5m 49.88%
2025
CHF-46.5m 19.15%
Unlock
2026
CHF-19.1m 58.91%
Unlock
2027
CHF14.8m 177.40%
Unlock
2028
CHF53.0m 258.71%
Unlock

EBITDA Margin

2024 -5.65% 42.87%
2025
-4.00% 29.26%
Unlock
2026
-1.39% 65.25%
Unlock
2027
0.93% 166.91%
Unlock
2028
2.73% 193.55%
Unlock

10 DocMorris Analysts have issued a net profit forecast 2025. The average DocMorris net profit estimate is

CHF-110m
Unlock
. This is
24.46% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF-94.8m 35.15%
Unlock
, the lowest is
CHF-125m 14.67%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF-97.3m 218.19%
2025
CHF-110m 13.48%
Unlock
2026
CHF-77.3m 29.98%
Unlock
2027
CHF-44.3m 42.62%
Unlock
2028
CHF-7.7m 82.61%
Unlock

Net Margin

2024 -9.56% 212.66%
2025
-9.51% 0.54%
Unlock
2026
-5.63% 40.80%
Unlock
2027
-2.79% 50.44%
Unlock
2028
-0.40% 85.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share CHF -4.06 -2.30
217.00% 43.35%
P/E negative
EV/Sales 0.32

10 Analysts have issued a DocMorris forecast for earnings per share. The average DocMorris EPS is

CHF-2.30
Unlock
. This is
54.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CHF-1.97 60.60%
Unlock
, the lowest is
CHF-2.60 48.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF-4.06 217.00%
2025
CHF-2.30 43.35%
Unlock
2026
CHF-1.61 30.00%
Unlock
2027
CHF-0.92 42.86%
Unlock
2028
CHF-0.16 82.61%
Unlock

P/E ratio

Current -1.24 44.90%
2025
-2.69 117.64%
Unlock
2026
-3.84 42.75%
Unlock
2027
-6.69 74.22%
Unlock
2028
-38.47 475.04%
Unlock

Based on analysts' sales estimates for 2025, the DocMorris stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.28 63.64%
2025
0.32 15.43%
Unlock
2026
0.27 15.38%
Unlock
2027
0.24 13.71%
Unlock
2028
0.19 18.26%
Unlock
2029
0.17 12.80%
Unlock
2030
0.15 10.82%
Unlock
2031
0.14 5.80%
Unlock
2032
0.13 5.73%
Unlock

P/S ratio

Current 0.21 61.54%
2025
0.25 15.68%
Unlock
2026
0.21 15.38%
Unlock
2027
0.18 13.71%
Unlock
2028
0.15 18.28%
Unlock
2029
0.13 12.82%
Unlock
2030
0.11 10.80%
Unlock
2031
0.11 5.79%
Unlock
2032
0.10 5.77%
Unlock

Current DocMorris Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JEFFERIES
Locked
Locked
Locked Sep 10 2025
BERENBERG
Locked
Locked
Locked Aug 20 2025
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Aug 19 2025
JEFFERIES
Locked
Locked
Locked Jul 17 2025
JEFFERIES
Locked
Locked
Locked Jul 16 2025
BERENBERG
Locked
Locked
Locked Jul 01 2025
BERENBERG
Locked
Locked
Locked Jun 30 2025
Analyst Rating Date
Locked
JEFFERIES:
Locked
Locked
Sep 10 2025
Locked
BERENBERG:
Locked
Locked
Aug 20 2025
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Aug 19 2025
Locked
JEFFERIES:
Locked
Locked
Jul 17 2025
Locked
JEFFERIES:
Locked
Locked
Jul 16 2025
Locked
BERENBERG:
Locked
Locked
Jul 01 2025
Locked
BERENBERG:
Locked
Locked
Jun 30 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today